Newsletter | June 17, 2021

06.17.21 -- Outlook: Biotech In 2021 & Beyond

Featured Editorial
Industry Insights
Why, Why, Why … ELISA? A Look At The Benchmark HCP Assay

Biologics developers and manufacturers demand an accurate and reliable assay for host cell protein (HCP) quantitation. Let’s take a close look at why analytical scientists turn to the ELISA, and how it fits into process development.

Innovating In The Viscosity Design Space For Handheld Combination Products: A New 2.25 mL Autoinjector Platform

Biologics are contributing to quality-of-life improvements for chronic disease sufferers. Simultaneously, innovations in the drug delivery device space are allowing for chronic disease sufferers to manage their drug therapies from home. Discover an autoinjector platform that reconciles the demands of biologics with safety, reliability, and ease of use during self-injection.

How Collaboration Transformed A Generic Into A Best-In-Class New Drug

Learn how a drug developer collaborated to transform a generic solid API into a commercial, sterile injectable approved by regulators.

6 Reasons You Don’t Use Pharmaceutical Market Research

If you're using one of these six excuses for ignoring pharma market research, you're failing to understand barriers to success, missing the market’s perspective, and leaving assumptions unvalidated.

News Headlines
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.